Pharmacokinetics of Azulfidine/Salazopyrin in healthy humans and in patients with chronic inflammatory bowel diseases
Van Hees, P.A.
Zeitschrift für Gastroenterologie. Verhandlungsband 19: 7-14
1981
ISSN/ISBN: 0172-8504 PMID: 6168136 Document Number: 169778
Document emailed within 1 workday
Related Documents
Fahrländer, H. 1981: Azulfidine/Salazopyrin therapy during pregnancy Zeitschrift für Gastroenterologie. Verhandlungsband 19: 24-26Müller, G.; Taube, C.; Senger, U.; Wagner, L. 1986: Thromboxane analyses in patients with chronic inflammatory bowel diseases Deutsche Zeitschrift für Verdauungs- und Stoffwechselkrankheiten 46(4): 243-246
Ewe, K. 1981: Effectiveness of Azulfidine/Salazopyrin in the postoperative prevention of recurrence in Crohn disease Zeitschrift für Gastroenterologie. Verhandlungsband 19: 41-44
Remvig, L.; Davidsen, B.; Kristensen, E. 1983: Immunologic findings in patients with chronic inflammatory bowel diseases. Crohn disease and ulcerative colitis Ugeskrift for Laeger 145(17): 1289-1293
Herrlinger, K.; Stange, E.F. 2004: Chronic inflammatory bowel diseases Deutsche Medizinische Wochenschrift 129(42): 2241-2250; Quiz 2251-2254
Schneider, W.; Hänert, E. 1991: Pregnancy and chronic inflammatory bowel diseases Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 46(16): 602-606
Ghermai, A.K. 1989: Chronic inflammatory bowel diseases in cats Tierarztliche Praxis 17(2): 195-199
Herfarth, C. 1983: Chronic inflammatory bowel diseases--indications for surgery Zeitschrift für Gastroenterologie. Verhandlungsband 18: 27-34
Faurschou, P.; Maltbaek, N.; Skov, B.G. 2005: Pulmonary diseases and chronic inflammatory bowel disease Ugeskrift for Laeger 167(1): 38-40
Heliö, T.; Paavola, P.; Halme, L.; Turunen, U.; Färkkilä, M.; Kontula, K. 2000: What is known about genetic factors behind chronic inflammatory bowel diseases? Duodecim; Laaketieteellinen Aikakauskirja 116(7): 713-718
Cellier, C.; Cervoni, J.P.; Patey, N.; Barbier, J.P.; Brousse, N. 1997: Cellular adherence and chronic inflammatory bowel diseases Gastroenterologie Clinique et Biologique 21(11): 832-842
Zeitz, M. 1997: New therapeutic possibilities in chronic inflammatory bowel diseases Praxis 86(25-26): 1071-1074
Folwaczny, C.; Fricke, H. 1998: Autoantibodies in chronic inflammatory bowel diseases: more than an epiphenomenon? Zeitschrift für Gastroenterologie 36(1): 105-108
Isbert, C.; Germer, C.T.; Albrecht, D.; Thomsen-Mund, K.; Schuppan, D.; Buhr, H.J. 1998: Overexpression of B7-1 amd B7-2 by LFA-1 positive lymphocytes in chronic inflammatory bowel diseases Langenbecks Archiv für Chirurgie. Suppl. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115(Suppl I): 213-216
Fajfr, M.; Stepánová, V. 2013: Cytomegalovirus and its relationship to chronic inflammatory bowel diseases and tumors Klinicka Mikrobiologie a Infekcni Lekarstvi 19(3): 103-106
Fahrländer, H. 1975: Are chronic inflammatory bowel diseases precancerous conditions?(author's transl) Leber Magen Darm 5(6): 272-274
Gower-Rousseau, C.; Grandbastien, B.; Colombel, J.F.; Cortot, A. 1997: Incidences of chronic inflammatory bowel diseases in France: the table is growing richer Gastroenterologie Clinique et Biologique 21(6-7): 481-482
Vinter-Repalust, N. 2015: Chronic Inflammatory Bowel Diseases – Specific Aspects of Family Physician Care Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 69(4): 395-399
Seibold, F.; Wagner, A.C.; Göke, B. 2000: Drug treatment of chronic inflammatory bowel diseases: current status and prospects Schweizerische Medizinische Wochenschrift 130(7): 222-232
Bouma, G.; Peña, A.S. 1999: Immunology in medical practice. XXVI. Immunogenetics of chronic inflammatory bowel diseases Nederlands Tijdschrift Voor Geneeskunde 143(48): 2414-2420